L‐662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals

Abstract

1 L-662,583 was a potent inhibitor in vitro of purified, human erythrocyte carbonic anhydrase II, pos-sessing an IC50 of 0.7 nm. The IC50 values for MK-927, acetazolamide and methazolamide were 13.0 nm, 10.8 nm and 21.2 nm, respectively. 2 A 1 h pretreatment with one 50 u1 drop of a 0.1% solution of L-662,583 blocked carbonic anhydrase activity in a homogenate of the iris + ciliary body of albino rabbits by 63%. Similar treatment with 0.1% suspensions of acetazolamide and methazolamide elicited inhibitions of 30% and 20%, respectively. This ex vivo model indirectly assesses the ability of an agent to enter the rabbit eye. 3 Concentrations of L-662,583 in the cornea, aqueous humour and iris + ciliary body of albino rabbits were determined by h.p.l.c. at predetermined times after the instillation (one drop of 50pl) of a 2% solution of L-662,583. Peak levels for cornea (47.4pgg-1), aqueous humour (4.51 ygml-1) and iris + ciliary body (9.61 pgg 1-) occurred at 0.5, 2 and 1 h after instillation, respectively. 4 The experimentally elevated intraocular pressure of the right eye of rabbits, induced by prior intraocular injection of a-chymotrypsin, was maximally decreased by 4.5 mmHg, 6.2 mmHg and 9.8 mmHg after the instillation (one drop of 50pl) of 0.01%, 0.1% and 0.5% solutions of L-662,583, respectively. All three concentrations lowered intraocular pressure at all time points from 1 h up to and including 5 h, the last recorded time point. The unilateral instillation of L-662,583 (0.5%) into the contralateral, left eye failed to lower the elevated intraocular pressure of the untreated, right eye. This finding indicates that the site of action of topically applied L-662,583 in this paradigm is local. The ocular normotensive, albino rabbit was much less susceptible than the ocular hypertensive rabbit to the intraocular pressure lowering effect of topically applied L-662,583, with a 2% solution maximally decreasing intraocular pressure by 2.3 mmHg. 5 Unilateral ocular hypertension was elicited in the right eye of sedated, cynomolgus monkeys by argon laser-induced photocoagulation of the trabecular meshwork. The instillation (one drop of 50p1) of L-662, 583 (2%) significantly lowered the elevated intraocular pressure of the right eye at all time points from 1 h up to and including 5 h. The maximum decline was 8.3 mmHg at 3 h and this represented a reduction of 23% from the corresponding baseline value of 36.8 mmHg. The intraocular pressure of the hypertensive, right eye was maximally decreased by 4.1 mmHg and 4.8 mmHg after the instillation of 0.5% and 1% solutions of L-662,583, respectively. Like the rabbit, the normotensive eye of cynomolgus monkeys was more resistant than the hypertensive eye to the ocular hypotensive action of L-662, 583, as indicated by the inability of 0.5% and 1% solutions of the agent to lower intraocular pressure. L-662,583 (2%) maximally reduced the intraocular pressure of normotensive monkey eyes by 2.4 mmHg at 2 h. 6 L-662,583 is structurally different from MK-927, a carbonic anhydrase inhibit...

Molecular Design for Enhancement of Ocular Penetration

“…Therefore, it is suggested that several-times higher ocular levels in rabbit are required for the sufficient efficacy in human. 55 …”

Assessment of bronchial effects following topical administration of butylamino‐phenoxy‐propanol‐acetate, an oculoselective beta‐ adrenoceptor blocker in asthmatic subjects.

“…But in studies with repeated lung function measurements within short intervals, evaluation of sGaw may offer the advantage to avoid full inspiration and forced expiratory manoeuvres, which can provide increased sensitivity (Tattersfield & Keeping, 1979). The very low flow and quasi-static conditions of sGaw measurements (Tattersfield & Keeping, 1979) (Kaback et al, 1976), and the o-pivalyl ester of a carbonic anhydrase inhibitor (Sugrue et al, 1985). In asthmatic subjects the (R)-enantiomer of timolol caused falls in sGaw and FEV1 being approximately four times less potent than timolol (Richards & Tattersfield, 1987).…”

Biopharmaceutical Explanation for the Topical Activity of 6-Hydroxyethoxy-2-Benzothiazolesulfonamide in the Rabbit Eye

“…CAase Inhibition tests were conducted on compounds 1-3 using the pH stat procedure (6,18). CAase Figure 1.…”